Improving Care

Reducing morbidity and mortality and enhancing quality of life

Informing Policy

Transforming health care at the local, national and international levels

Featured Projects

With more than 80 scientists, research at Advancing Health encompasses a wide breadth of areas

COVID-19

The Evidence Speaks

A recurring feature highlighting the latest in Advancing Health research

Our People

In the News

Research Resources

From design to execution, Advancing Health provides a broad range of support services

Work in Progress Seminar Series

Publications

The work of our scientists, research associates, and staff are often found in the pages of top journals. Each year, our researchers publish over 400 peer-reviewed papers.


  • Humphries KH: Reduction of LDL with ezetimibe

    July 24, 2017

    Humphries KH, Mancini GBJ. Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: Are mechanistic considerations warranted in practice? Eur Heart J.  2017 May 19 epub ahead of print.

    Read More

  • Anis AH et al.: Treatment and perceptions of outcomes in SALOME

    July 24, 2017

    Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E. Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder. Subst Abuse Treat Prev Policy. 2017 May 19;12(1):25.

    Read More

  • Ayas NT: Sleep disordered breathing 2016

    July 24, 2017

    Ayas NT, Drager LF, Morrell MJ, Polotsky VY. Update in sleep disordered breathing 2016. Am J Respir Crit Care Med. 2017 May 21 epub ahead of print.

    Read More

  • Richardson CG, Mathias S: Naloxone and the Inner City Youth Experience

    July 24, 2017

    Mitchell K, Durante SE, Pellatt K, Richardson CG, Mathias S, Buxton JA. Naloxone and the Inner City Youth Experience (NICYE): a community-based participatory research study examining young people’s perceptions of the BC take home naloxone program. Harm Reduct J. 2017 Jun 7;14(1):34.

    Read More

  • Oviedo-Jokes E, Anis AH, Krausz M, Schechter MT: Characteristics and response to treatment among Indigenous

    July 24, 2017

    Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT. Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence. Drug Alcohol Rev. 2017 Jun 8;23:76.

    Read More

  • Stenstrom R: Between- and within-site variation in medication choices

    July 24, 2017

    Clinkard D, Stiell I, Lang E, Rose S, Clement C, Brison R, Rowe BH, Borgundvaag B, Langhan T, Magee K, Stenstrom R, Perry JJ, Birnie D, Wells G, McRae A. Between- and within-site variation in medication choices and adverse events during procedural sedation for electrical cardioversion of atrial fibrillation and flutter. CJEM. 2017 June 7:1-7 epub ahead of print.

    Read More

  • Cundiff GW: Perinatal and maternal morbidity and mortality

    July 24, 2017

    Muraca GM, Sabr Y, Lisonkova S, Skoll A, Brant R, Cundiff GW, Joseph KS. Perinatal and maternal morbidity and mortality after attempted operative vaginal delivery at midpelvic station. CMAJ. 2017 Jun 5;189(22):E764-E772.

    Read More

  • Grunau BE: Prevalence, natural history, and time-dependent outcomes

    September 25, 2017

    Reynolds JC, Grunau BE, Elmer J, Rittenberger JC, Sawyer KN, Kurz MC, Singer B, Proudfoot A, Callaway CW. Prevalence, natural history, and time-dependent outcomes of a multi-center North American cohort of out-of-hospital cardiac arrest extracorporeal CPR candidates. Resuscitation. 2017 May 25;117:24-31 epub ahead of print.

    Read More

  • Bansback N, Anis AH: Triple therapy versus biologic therapy

    July 24, 2017

    Bansback N, Phibbs CS, Sun H, O’Dell JR, Brophy M, Keystone EC, Leatherman S, Mikuls TR, Anis AH, CSP 551 RACAT Investigators. Triple therapy versus biologic therapy for active rheumatoid arthritis: A cost-effectiveness analysis. Ann Intern Med. 2017 May 30. Epub ahead of print.

    Read More

  • Li LC, Bansback N: Effects of a web-based patient decision aid

    July 24, 2017

    Li LC, Shaw C, Lacaille D, Yacyshyn E, Jones CA, Koehn C, Hoens AM, Geldman J, Sayre EC, Macdonald G, Leese J, Bansback N. Effects of a web-based patient decision aid on biologic and small molecule agents for rheumatoid arthritis, ANSWER-2: A Proof-of-concept study. Arthritis Care Res (Hoboken). 2017 May 23. Epub ahead of print.

    Read More

  • Gill J: Expectations and experiences of follow up and self-care

    July 24, 2017

    Manera KE, Hanson CS, Chapman JR, Kanellis J, Gill J, Craig JC, Chadban SJ, Wong G, Ralph AF, Tong A. Expectations and experiences of follow up and self-care after living kidney donation: A focus group study. Transplantation. 2017 May 24 epub ahead of print.

    Read More

  • Li LC: Patients engagement in rheumatology research

    July 24, 2017

    Hamilton CB, Leese JC, Hoens AM, Li LC. Framework for advancing the reporting of patient engagement in rheumatology research projectsCurr Rheumatol Rep. 2017 Jun 19;19(7):38.

    Read More